1[1]Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J of Exp Med, 1989,170: 827-845.
2[2]Charbonnier A, Gaugler B, Sainty D, et al. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol, 1999,29:2567-78.
3[3]Aguilar-Santelises M, Gigliotti D, Osorio LM, et al. Cytokine expression in B-CLL in relation to disease progression and in vitro activation. Med Oncol, 1999,16:289-95.
4[4]Stasi R,Zinnani PL, Glien P,et al. Clinical implications of cytokine and soluble and receptor measurements in patients with newly diagnosed aggressive non-Hodgkins lymphoma. Eur J Hacmatol, 1995,54:9-17.
5[5]Denizot Y, Fixe P, Liozon E, et al. Serum IL6 concentrations in lymphomasa. Br J Haematol, 1995,90:731-733.
6[7]Jared A, Gollob, Erin A, et al. Altered interleukinl2 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. Blood, 1998,91 (4) :1341-1354.
7[8]Kubin M, Chow JM, Trinchieri G, et al. Differential regulation of interleukin-12 ( IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood, 1994,83:1847-55.
8Thomassen E, Bird TA, Renshaw BR, et al. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1 Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J Interferon Cytokine Res, 1998; 18:1077- 1088.
9Dao T, Ohashi K, Kayano T, et al. Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol, 1996; 173:230-235.
10Tsutsui H, Kayagaki N, Kuida K, et al. Caspase-l-independent,Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity, 1999; 11:359 -367.
1Castro FV,McGinn OJ,Krishnan S,et al. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype[J]. Leukemia, 2012,26 (7) : 1487-1498.
2Krawczuk-Rybak M, Ku z micz M, Mroczko B, et al. Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia [J]. Pol Merkur Lekarski,2010,29(169) :14-18.
